Frank C. Hampel
Central Texas Health Research
New Braunfels
Texas 78130
USA
Name/email consistency: high
- Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria. Hampel, F., Ratner, P., Haeusler, J.M. Allergy. Asthma. Proc (2010)
- Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. Hampel, F.C., Kittner, B., van Bavel, J.H. Ann. Allergy Asthma Immunol. (2007)
- Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo. Hampel, F.C., Ratner, P.H., Amar, N.J., van Bavel, J.H., Mohar, D., Fairchild, C.J., Wall, G.M., Brubaker, M.J., Drake, M., Crenshaw, K.M. Allergy. Asthma. Proc (2006)
- A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis. Hampel, F., Howland, W., Van Bavel, J., Ratner, P. J. Investig. Allergol. Clin. Immunol (2004)
- Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Hampel, F., Ratner, P., Mansfield, L., Meeves, S., Liao, Y., Georges, G. Ann. Allergy Asthma Immunol. (2003)
